Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamika Gune

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Ophthalmology. Retina|April 22, 2023
Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular DegenerationBarbara A Blodi, Amitha Domalpally, Ellie Corkery, et al.
Retina (Philadelphia, Pa.)|January 24, 2020
MACULAR ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Pilot Post Hoc Analysis of Patients With Pigment Epithelial DetachmentsCarl B Rebhun, Carlos Moreira-Neto, Shamika Gune, et al.
American Journal of Ophthalmology|July 21, 2021
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular DegenerationNancy M Holekamp, Srinivas Sadda, David Sarraf, et al.
Ophthalmology|November 14, 2019
Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular DegenerationShamika Gune, Nizar Saleh Abdelfattah, Ayesha Karamat, et al.
Ophthalmology|May 13, 2018
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISERahul K Reddy, Dante J Pieramici, Shamika Gune, et al.
Ophthalmology|August 28, 2016
Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR StudyDavid Sarraf, Nikolas J S London, Rahul N Khurana, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 10, 2022
Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysisSriniVas Sadda, Nancy M Holekamp, David Sarraf, et al.
Ophthalmology|May 14, 2020
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular DegenerationSriniVas R Sadda, Nizar Saleh Abdelfattah, Jianqin Lei, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 3, 2022
Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBORK Bailey Freund, Giovanni Staurenghi, Jesse J Jung, et al.
Ophthalmology. Retina|October 24, 2024
Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab InjectionsVeeral S Sheth, Nancy M Holekamp, Arshad M Khanani, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Ophthalmology. Retina|April 22, 2023
Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular DegenerationBarbara A Blodi, Amitha Domalpally, Ellie Corkery, et al.
Retina (Philadelphia, Pa.)|January 24, 2020
MACULAR ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Pilot Post Hoc Analysis of Patients With Pigment Epithelial DetachmentsCarl B Rebhun, Carlos Moreira-Neto, Shamika Gune, et al.
American Journal of Ophthalmology|July 21, 2021
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular DegenerationNancy M Holekamp, Srinivas Sadda, David Sarraf, et al.
Ophthalmology|November 14, 2019
Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular DegenerationShamika Gune, Nizar Saleh Abdelfattah, Ayesha Karamat, et al.
Ophthalmology|May 13, 2018
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISERahul K Reddy, Dante J Pieramici, Shamika Gune, et al.
Ophthalmology|August 28, 2016
Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR StudyDavid Sarraf, Nikolas J S London, Rahul N Khurana, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 10, 2022
Relationship between retinal fluid characteristics and vision in neovascular age-related macular degeneration: HARBOR post hoc analysisSriniVas Sadda, Nancy M Holekamp, David Sarraf, et al.
Ophthalmology|May 14, 2020
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular DegenerationSriniVas R Sadda, Nizar Saleh Abdelfattah, Jianqin Lei, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 3, 2022
Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBORK Bailey Freund, Giovanni Staurenghi, Jesse J Jung, et al.
Ophthalmology. Retina|October 24, 2024
Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab InjectionsVeeral S Sheth, Nancy M Holekamp, Arshad M Khanani, et al.
Pageof 4